Compare AVA & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVA | RGC |
|---|---|---|
| Founded | 1889 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Power Generation | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.1B |
| IPO Year | 1994 | 2020 |
| Metric | AVA | RGC |
|---|---|---|
| Price | $35.18 | $6.14 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $39.00 | N/A |
| AVG Volume (30 Days) | ★ 577.0K | 161.3K |
| Earning Date | 05-05-2026 | 10-31-2025 |
| Dividend Yield | ★ 4.84% | N/A |
| EPS Growth | ★ 3.93 | N/A |
| EPS | ★ 1.54 | N/A |
| Revenue | ★ $1,964,000,000.00 | N/A |
| Revenue This Year | $3.11 | N/A |
| Revenue Next Year | $4.44 | N/A |
| P/E Ratio | $22.76 | ★ N/A |
| Revenue Growth | ★ 1.34 | N/A |
| 52 Week Low | $34.98 | $4.51 |
| 52 Week High | $43.50 | $69.00 |
| Indicator | AVA | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 27.49 | 53.17 |
| Support Level | N/A | $5.48 |
| Resistance Level | $42.10 | $6.22 |
| Average True Range (ATR) | 0.54 | 0.42 |
| MACD | -0.09 | 0.06 |
| Stochastic Oscillator | 17.85 | 41.64 |
Avista Corp is an electric and natural gas utility company. The company has two business segments including Avista Utilities, which provides electric distribution and transmission, and natural gas distribution services in parts of eastern Washington and northern Idaho, and also provides natural gas distribution service in parts of northeastern and southwestern Oregon. Avista Utilities has electric generating facilities in Washington, Idaho, Oregon, and Montana. AEL&P segment is a regulated utility providing electric services in Juneau, Alaska that is a wholly-owned subsidiary and the primary operating subsidiary of AERC.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.